Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Neurosterix pockets $105m to advance neuropsychiatry pipeline

Nov 13, 2026, 11:28 AM

Read Full Article → Neurosterix pockets $105m to advance neuropsychiatry pipeline

Neurosterix pockets $105m to advance neuropsychiatry pipeline

Translate article text

Choose a language and wait for the translated text.

Neurosterix hopes that NTX-253 may compete with BMS’s Cobenfy as the schizophrenia field explores mechanisms past dopamine modulation.

Neurosterix pockets $105m to advance neuropsychiatry pipeline | PharmaVoice